GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,323 | -11.8% | 4,839 | 0.0% | 0.00% | – |
| Q2 2023 | $9,436 | -93.0% | 4,839 | -53.5% | 0.00% | -100.0% |
| Q4 2021 | $133,924 | +19.1% | 10,414 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $112,471 | +15.7% | 10,414 | -2.2% | 0.00% | +100.0% |
| Q2 2021 | $97,225 | +34.3% | 10,649 | +38.7% | 0.00% | 0.0% |
| Q1 2021 | $72,394 | +5.8% | 7,677 | -25.5% | 0.00% | 0.0% |
| Q2 2020 | $68,432 | +27.3% | 10,306 | +11.6% | 0.00% | 0.0% |
| Q1 2020 | $53,736 | -36.0% | 9,233 | -5.1% | 0.00% | 0.0% |
| Q3 2019 | $84,019 | +255.4% | 9,730 | +358.5% | 0.00% | – |
| Q2 2019 | $23,639 | – | 2,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |